El Salvador vs Western Pacific (WHO region): Pneumococcal conjugate second or third-dose vaccines (PCVc)
El Salvador
98.0%
in 2025
Western Pacific (WHO region)
34.0%
in 2025
El Salvador rank
11th
Western Pacific (WHO region) rank
11th
Pneumococcal conjugate second or third-dose vaccines (PCVc) over time
- El Salvador
- Western Pacific (WHO region)
How they compare
El Salvador currently reports 98.0% against 34.0% in Western Pacific (WHO region), a difference of 64.0%.
That makes El Salvador's figure about 2.9 times Western Pacific (WHO region)'s.
The two have swapped places 1 time across 18 shared years of data; in 2008 it was Western Pacific (WHO region) ahead.
El Salvador ranks 11th and Western Pacific (WHO region) ranks 11th of 194 countries.
Across the 3 decades both report, El Salvador averaged higher in 2 and Western Pacific (WHO region) in 1.
Head to head by decade
| Decade | El Salvador | Western Pacific (WHO region) | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 1.0% | 1.0% | Western Pacific (WHO region) |
| 2010s | 91.0% | 7.8% | 83.2% | El Salvador |
| 2020s | 94.7% | 24.8% | 69.8% | El Salvador |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc), El Salvador or Western Pacific (WHO region)?
- El Salvador, at 98.0% against 34.0% in Western Pacific (WHO region) as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) between El Salvador and Western Pacific (WHO region)?
- 64.0%, with El Salvador ahead.
- How many years of comparable data are there for El Salvador and Western Pacific (WHO region)?
- 18 years are reported by both, from 2008 to 2025.
- How do El Salvador and Western Pacific (WHO region) rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- El Salvador ranks 11th and Western Pacific (WHO region) ranks 11th of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.